2025
SJR Q2
JCR Q2 · 4,9
24 eşleşen makale
SCIE
Dergi ayrıntısı
Stem Cell Reviews and Reports
- Yayıncı
- Springer
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
2629326926293277
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,217
- Quartile Q2
- H-Index 96
- Atıf/yayın 4,47
- Doküman (3y) 550
- Atıf (3y) 2.754
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4,9
- 5Y JIF 4,9
- JCI 0,88
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Cancer Research Q2
- Cell Biology Q2
Alanlar
- Biochemistry, Genetics and Molecular Biology
WoS kategorileri
- Cell & Tissue Engineering | Cell Biology | Medicine, Research & Experimental
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 1,217 | 4,9 | 4,9 | 0,88 | Q2 | 96 |
| 2024 | Q2 | Q2 | 1,219 | 4,2 | 4,5 | 0,92 | Q2 | 91 |
| 2023 | Q2 | Q2 | 1,19 | 4,5 | 4,7 | 0,98 | Q2 | 91 |
| 2022 | Q2 | Q2 | 1,067 | 4,8 | 4,7 | 0,97 | Q1 | 91 |
| 2021 | Q2 | Q1 | 1,078 | 6,7 | 6 | 1,12 | Q1 | 91 |
| 2020 | Q2 | Q2 | 1,247 | 5,7 | 5,2 | 1,08 | Q1 | 91 |
| 2019 | Q2 | Q1 | 1,408 | 5,3 | 4,5 | 1,09 | Q2 | 91 |
| 2018 | — | Q1 | — | 4,7 | 4,1 | 1,12 | Q1 | — |
| 2017 | Q2 | Q2 | 1,323 | 3,6 | 3,4 | 0,94 | Q2 | 91 |
| 2016 | Q2 | Q2 | 1,225 | 3 | 3,3 | — | — | 91 |
| 2015 | Q2 | Q2 | 1,461 | 3,1 | 3,6 | — | — | 91 |
| 2014 | Q2 | Q2 | 1,564 | 2,8 | 3,4 | — | — | 91 |
| 2013 | Q2 | Q2 | 1,565 | 3,2 | 3,3 | — | — | 91 |
| 2012 | Q2 | Q1 | 1,69 | 4,5 | 4,5 | — | — | 91 |
| 2011 | Q2 | Q1 | 1,634 | 3,7 | 3,7 | — | — | 91 |
| 2010 | Q2 | Q3 | 1,952 | 1,7 | 1,7 | — | — | 91 |
| 2009 | — | — | — | — | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CELL BIOLOGY | SCIE | Q2 | Q2 | 78/207 |
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 11/32 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 52/191 |
| 2024 | CELL BIOLOGY | SCIE | Q2 | Q2 | 85/204 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 12/32 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 56/195 |
| 2023 | CELL BIOLOGY | SCIE | Q2 | Q2 | 72/205 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 10/31 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 52/189 |
| 2022 | CELL BIOLOGY | SCIE | Q2 | Q2 | 82/191 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 10/29 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 53/136 |
| 2021 | CELL BIOLOGY | SCIE | Q2 | Q1 | 61/195 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 9/29 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 34/139 |
| 2020 | CELL BIOLOGY | SCIE | Q2 | Q2 | 65/195 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 11/29 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 36/140 |
| 2019 | CELL BIOLOGY | SCIE | Q2 | Q2 | 52/195 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 9/29 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q2 | 23/139 |
| 2018 | CELL BIOLOGY | SCIE | Q2 | Q1 | 58/193 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q1 | Q1 | 6/26 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 28/136 |
| 2017 | CELL BIOLOGY | SCIE | Q2 | Q2 | 83/190 |
| 2017 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 12/24 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 44/133 |
| 2016 | CELL BIOLOGY | SCIE | Q3 | — | 106/190 |
| 2016 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 14/21 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 44/128 |
| 2015 | CELL BIOLOGY | SCIE | Q3 | — | 97/187 |
| 2015 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 14/21 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 42/124 |
| 2014 | CELL BIOLOGY | SCIE | Q3 | — | 112/184 |
| 2014 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 14/21 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 49/123 |
| 2013 | CELL BIOLOGY | SCIE | Q3 | — | 96/185 |
| 2013 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 11/18 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 38/124 |
| 2012 | CELL BIOLOGY | SCIE | Q2 | — | 56/185 |
| 2012 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 5/17 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 21/121 |
| 2011 | CELL BIOLOGY | SCIE | Q2 | — | 74/181 |
| 2011 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 6/12 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 26/112 |
| 2010 | CELL BIOLOGY | SCIE | Q4 | — | 142/178 |
| 2010 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 11/13 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 58/106 |
| 2009 | CELL BIOLOGY | SCIE | — | — | — |
| 2009 | CELL & TISSUE ENGINEERING | SCIE | — | — | — |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | — | — | — |